Docoh
Loading...

346 results

Filter options loading...
Top filers
Top filing types
Recent filing years
144
Schneider Debra A
14 Jun 10
Notice of proposed sale of securities
8:00pm
Nature of Acquisition Transaction Name of Person from Whom Acquired (If gift, also give date donor acquired) Amount of Securities Acquired Date … of Payment Nature of Payment Common Stock Stock option exercise Transgenomic, Inc. Check INSTRUCTIONS: If the securities were purchased and full payment
144
Cohen David Seth
3 Aug 21
Notice of proposed sale of securities
1:05pm
: Title of the Class Date you Acquired Nature of Acquisition Transaction Name of Person from Whom Acquired (If gift, also give date donor acquired … ) Amount of Securities Acquired Date of Payment Nature of Payment Common Stock, par value $0.01 per share 6/29/2017 11/29/2018 12/31/2018 Merger Senior
10-Q
2010 Q1
EX-10.1
PRPO Precipio Inc
5 May 10
Quarterly report
8:00pm
, actions or rights of action, known or unknown, of whatever character and nature, arising from or related in any way to any claim he may have against any … , whether of a technical nature or otherwise, as well as information related to pending patent applications. Dr. Kaldjian further understands
8-K
EX-10.1
PRPO Precipio Inc
5 Nov 17
Entry into a Material Definitive Agreement
7:00pm
, assessments and encumbrances of any kind or nature , and has the unrestricted power to settle such Outstanding Amount. (c) Each Vendor (i) understands … as are reasonably incidental thereto. The Collateral Agent may perform any of its duties hereunder by or through its agents or employees. 2.NATURE OF DUTIES
8-K
EX-10.1
PRPO Precipio Inc
20 Sep 18
Entry into a Material Definitive Agreement
4:13pm
and is in good standing in every jurisdiction in which its ownership of property or the nature of the business conducted by it makes such qualification … , village, district, or other political jurisdiction of any nature, federal, state, local, municipal, foreign, or other government, governmental or quasi
10-K
EX-10.13
cmgol8njf2fiqxz
24 Mar 02
Annual report
7:00pm
8-K
EX-10.2
v8ztfi9966
5 Nov 17
Entry into a Material Definitive Agreement
7:00pm
8-K
EX-99.1
l95u9hehcbhwmyv6dir
21 Mar 04
Other events
7:00pm
8-K
EX-10.1
3zad78
7 Feb 13
Entry into a Material Definitive Agreement
7:00pm
CORRESP
aat s4jxwayqvau
23 Apr 17
Correspondence with SEC
8:00pm
10-K/A
qrb8gz747vu8o3s2f
20 Oct 11
Annual report (amended)
8:00pm
144
kgg5qr9v9hbtco
17 Jun 21
Notice of proposed sale of securities
8:31am
8-K
EX-10.1
sk01vg6byjz5
3 Jan 11
Transgenomic Announces Closing of the Acquisition of Clinical Data’s Diagnostic Business and the Closing of a $6 Million Financing
7:00pm
10-Q
EX-10.2
mtjgle
11 Nov 02
Quarterly report
7:00pm
10-Q
EX-10.7
5x1eh gjrp
13 Nov 13
Quarterly report
7:00pm
8-K
EX-10.1
0fytc03lp s4da
5 Mar 14
Transgenomic Announces $7 Million Convertible Preferred Stock Financing
7:00pm
10-K
EX-10.21
at7gd lzig
26 Mar 14
Annual report
8:00pm
8-K
EX-10.1
kdwyqn bjlncjm
27 Jan 14
Material Modifications to Rights of Security Holders
7:00pm
S-8
EX-4
73398g
15 Jan 07
Registration of securities for employees
7:00pm
S-1
EX-10.17
ghz597qbfx7c12p
9 Mar 00
IPO registration
7:00pm